168 related articles for article (PubMed ID: 15656825)
1. Angiokeratomas, Fabry disease and enzyme replacement therapy: still a challenge.
Möhrenschlager M; Henkel V; Ring J
Br J Dermatol; 2005 Jan; 152(1):177-8; author reply 178-9. PubMed ID: 15656825
[No Abstract] [Full Text] [Related]
2. A case of multiple angiomas without any angiokeratomas in a female heterozygote with Fabry disease.
Mirceva V; Hein R; Ring J; Möhrenschlager M
Australas J Dermatol; 2010 Feb; 51(1):36-8. PubMed ID: 20148840
[TBL] [Abstract][Full Text] [Related]
3. Angiokeratomas - When is a few too many?
O'Mahony C; Franks A; Llewellyn R
Int J STD AIDS; 2014 Apr; 25(5):378-9. PubMed ID: 24104692
[TBL] [Abstract][Full Text] [Related]
4. A family with Fabry disease diagnosed by a single angiokeratoma.
Corry A; Feighery C; Alderdice D; Stewart F; Walsh M; Dolan OM
Dermatol Online J; 2011 Apr; 17(4):5. PubMed ID: 21549080
[TBL] [Abstract][Full Text] [Related]
5. Misdiagnosis of Fabry disease: importance of biochemical confirmation of clinical or pathological suspicion.
Linthorst GE; De Rie MA; Tjiam KH; Aerts JM; Dingemans KP; Hollak CE
Br J Dermatol; 2004 Mar; 150(3):575-7. PubMed ID: 15030345
[TBL] [Abstract][Full Text] [Related]
6. Fabry disease: case report with emphasis on enzyme replacement therapy and possible future therapeutic options.
Möhrenschlager M; Pontz BF; Lanzl I; Podskarbi T; Henkel V; Ring J
J Dtsch Dermatol Ges; 2007 Jul; 5(7):594-7. PubMed ID: 17610610
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous complications of Anderson-Fabry disease.
Giuseppe P; Daniele R; Rita BM
Curr Pharm Des; 2013; 19(33):6031-6. PubMed ID: 23448454
[TBL] [Abstract][Full Text] [Related]
8. Angiokeratomas and treatment with enzyme replacement therapy in a patient with Fabry disease.
Merzel Šabović EK; Žerjav Tanšek M; Grošelj U; Dragoš V
Acta Dermatovenerol Alp Pannonica Adriat; 2020 Jun; 29(2):89-91. PubMed ID: 32566958
[TBL] [Abstract][Full Text] [Related]
9. Angiokeratoma regression in a Fabry disease after treatment with agalsidase-beta: clinical effectiveness marker?
Fauchais AL; Prey S; Ouatara B; Vidal E; Sparsa A
J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):737-8. PubMed ID: 19925601
[No Abstract] [Full Text] [Related]
10. Fabry disease: clinical features and recent advances in enzyme replacement therapy.
Desnick RJ; Wasserstein MP
Adv Nephrol Necker Hosp; 2001; 31():317-39. PubMed ID: 11692469
[No Abstract] [Full Text] [Related]
11. Skin manifestations of Fabry disease.
Möhrenschlager M; Ring J; Abeck D
JAMA; 2001 Sep; 286(11):1315. PubMed ID: 11560533
[No Abstract] [Full Text] [Related]
12. Fabry disease and the clinical spectrum of angiokeratomas.
Guinovart RM; Bielsa I; Pintos-Morell G; Ferrándiz C
Actas Dermosifiliogr; 2013 Apr; 104(3):261-3. PubMed ID: 22975414
[No Abstract] [Full Text] [Related]
13. [Nevoid angiokeratoma].
Trofimova IB; Aĭvazian AA
Vestn Dermatol Venerol; 1988; (6):28-31. PubMed ID: 3140505
[No Abstract] [Full Text] [Related]
14. Angiokeratoma of the nasal vestibule: a case report.
Öztürk M; Erdoğan S; Kara A; Sarı F
Kulak Burun Bogaz Ihtis Derg; 2014; 24(6):361-3. PubMed ID: 25547753
[TBL] [Abstract][Full Text] [Related]
15. [Fabry's disease. An orphan disease that has found a solution: enzymatic replacement with alpha-galactosidase].
Selgas R; García de Lorenzo A; Valdés F; Beck M
Nefrologia; 2001; 21(5):443-7. PubMed ID: 11795012
[No Abstract] [Full Text] [Related]
16. Genital angiokeratoma in a woman with Fabry disease: the dermatologist's role.
Jesus PMR; Martins AM; Chiacchio ND; Aranda CS
An Bras Dermatol; 2018 Jun; 93(3):426-428. PubMed ID: 29924222
[TBL] [Abstract][Full Text] [Related]
17. Angiokeratomas in Fabry disease.
Mutoh H; Konoshita T; Onoe T; Makino Y; Arakawa K; Nakamura H;
Am J Med Sci; 2013 Oct; 346(4):302. PubMed ID: 22990047
[No Abstract] [Full Text] [Related]
18. [Manifestation of Fabry disease in a heterozygous female patient. New perspectives using enzyme replacement therapy].
Jansen T; Brokalaki E; Hillen U; Hentschke M; Grabbe S
Dtsch Med Wochenschr; 2006 Jul; 131(28-29):1590-3. PubMed ID: 16823707
[TBL] [Abstract][Full Text] [Related]
19. Fabry disease: angiokeratoma, biomarker, and the effect of enzyme replacement therapy on kidney function.
Ries M; Schiffmann R
Arch Dermatol; 2005 Jul; 141(7):904-5; author reply 905-6. PubMed ID: 16027312
[No Abstract] [Full Text] [Related]
20. Update on Fabry disease: kidney involvement, renal progression and enzyme replacement therapy.
Breunig F; Wanner C
J Nephrol; 2008; 21(1):32-7. PubMed ID: 18264934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
